Stunted Growth

 | Jun 25, 2012 | 12:30 PM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

utx

,

nue

,

pll

,

fdx

,

jbl

,

adbe

,

adsk

,

txn

,

cah

,

bbby

,

pg

,

dri

This commentary originally appeared at 8:11 a.m. EDT on June 25 on Real Money Pro -- for access to all of legendary hedge fund manager Doug Kass's strategies and commentaries, click here.

Worldwide growth forecasts are being revised lower.

Indeed, our markets/economy and politicians seem to be operating on different timelines. I had been hopeful that our leaders and policymakers would finally recognize the reduced effectiveness of more cowbell (easing of monetary policy) and that they would at least have started a dialogue on the implementation of pro-growth fiscal policy aimed toward whittling down the fiscal cliff and/or postponing its impact -- all sooner than later in order to prevent a possible adverse and negative feedback loop.

Over there, the worsening sovereign debt crisis, and structurally flawed eurozone continues to weigh on the global economic recovery. Eurozone leaders and central bankers, seeking to seal one sovereign fissure at a time, remain behind the curve but, hopefully, are preparing to catch up and abandon Germany's gradualism as attention is focused on the June 28/June 29 Brussels Summit and the ECB's July 5 meetings.

Consensus Profit Forecasts Are in Jeopardy

With political cohesion absent domestically, U.S. business and consumer confidence has been victimized. In turn, profit disappointments are multiplying and will accelerate further unless our leaders abandon their divisive, divided and dysfunctional behavior. Witness the already weaker-than-expected industrial earnings at United Technologies (UTX), Nucor (NUE), Pall (PLL), FedEx (FDX), Jabil Circuit (JBL), Adobe Systems (ADBE), Autodesk (ADSK), Texas Instruments (TXN) and Cardinal Health (CAH) and the poor results at consumer-based Bed Bath & Beyond (BBBY), Procter & Gamble (PG) and Darden Restaurants (DRI).

Meanwhile, as mentioned previously, the domestic economic downturn is broadening geographically and the notion of a self-sustaining developed world economic recovery is starting to fade:

  • The U.S. economy still seems capable of muddling through 2012-2013, and real GDP growth seems likely to grow annually at 2.0%.
  • Real GDP growth forecasts for the Chinese economy are estimated at approximately 7% annually over the next two years, but projections have started to waver.
  • Estimates for the eurozone's growth are still -0.5% in 2012 and zero growth to +0.5% next year, but these forecasts are obviously in jeopardy.
  • In total, developing economies are expected to grow by slightly more than 1% in 2012, with some modest acceleration toward 1.5% in 2013, less than half the growth experienced in the last cyclical recovery.
  • In the aggregate, the world's emerging markets are projected to grow by about 4.5% in 2012 and accelerate to 5.0% growth in 2013.

"History doesn't repeat itself -- at best, it sometimes rhymes."

-- Mark Twain

I have been of the belief that history demonstrates that the world's leaders rise up at times of crisis.

While history rhymes, I remain hopeful that 2012 will not rhyme with 2008.

I hope we are not disappointed (again) this time.

Fortunately, against this backdrop, investors' economic and market expectations are muted, and many classes of investors have de-risked. Valuations remain low and risk premiums remain high. Also, the fall in commodities (especially of an energy kind) remains a positive as does generational low interest rates in the U.S.

Unfortunately, valuations fail as a timing tool, and one of the reasons behind lower commodities is reduced demand.

Tactically (over the near term), I plan to continue to err on the side of conservatism in my trading and investing in a summer market likely characterized by choppiness and the absence of a trend.

Columnist Conversations

We are still seeing WYNN hold up above key WEEKLY support here, but I do want to show you what is in the way o...
Market moving down in last hour as dollar continues to strengthen against major currencies, commodity prices a...
The daily chart of Regeneron Phamaceuticals (REGN) shows Bollinger bandwidth contraction at a reading that, i...
Can really run on this new phase two data--I would buy it right here ...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.